At close: January 8 at 3:59:39 PM EST
Pre-Market: 8:48:39 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DAVIS TODD CLIFTON Director | Conversion of Exercise of derivative security | Feb 21, 2024 | 29,167 |
| FRANCIS KNUETTEL II Chief Executive Officer | Purchase | Sep 13, 2024 | -- |
| FRIEDBERG EZRA M Director | Conversion of Exercise of derivative security | Feb 21, 2024 | -- |
| MALAMUT RICHARD Director | Purchase | Sep 12, 2024 | -- |
Related Tickers
MRES Institute of Biomedical Research Corp.
0.0156
+18.03%
DOMH Dominari Holdings Inc.
1.1780
+1.55%
ESLA Estrella Immunopharma, Inc.
1.1100
-7.50%
CNTB Connect Biopharma Holdings Limited
1.1150
-3.04%
LIPO Lipella Pharmaceuticals Inc.
3.1700
-1.86%
ENVB Enveric Biosciences, Inc.
0.4159
-17.63%
PTIX Protagenic Therapeutics, Inc.
0.5482
-5.14%
TNFA TNF Pharmaceuticals, Inc.
1.2800
+8.94%
LVTX LAVA Therapeutics N.V.
1.0200
-5.56%
ANTX AN2 Therapeutics, Inc.
1.3000
-3.70%